Pharmacogenetic approaches to rheumatoid arthritis

This publication has 27 references indexed in Scilit:

• Pharmacogenetics goes genomic
  Nature Reviews Genetics, 2003
• Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea
  Rheumatology, 2003
• Is thiopurine methyltransferase genetic polymorphism a major factor for withdrawal of azathioprine in rheumatoid arthritis patients?
  Rheumatology, 2003
• A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity
  Molecular Genetics and Metabolism, 1998
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
  Carcinogenesis: Integrative Cancer Research, 1993
• Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.
  Annals of the Rheumatic Diseases, 1991
• The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalyses
  Arthritis & Rheumatism, 1990
• TOLERABILITY OF ENTERIC-COATED SULPHASALAZINE IN RHEUMATOID ARTHRITIS: RESULTS OF A CO-OPERATING CLINICS STUDY
  Rheumatology, 1990
• The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients
  Arthritis & Rheumatism, 1988